Scientific publications

Twists and turns to translating 4-1BB cancer immunotherapy. Scientific Publication

Jun 12, 2019 | Magazine: Science Translational Medicine

Miguel F Sanmamed, Iñaki Etxeberría, Itziar Otano, Ignacio Melero

Abstract

Previous shortcomings of CD137-targeted immunotherapy may be overcome by engineered bispecific agents (Claus et al, this issue).

CITATION Sci Transl Med. 2019 Jun 12;11(496):eaax4738. doi: 10.1126/scitranslmed.aax4738.

see publication in pubmed

Our authors

Imagen del Dr. Miguel Fernández de Sanmamed Gutiérrez, Investigador principal del grupo Onco-Inmunología Aplicada y Traslacional de la Clínica Universidad de Navarra
Dr. Miguel Fernández de Sanmamed Gutiérrez Curriculum
Researcher | Principal Investigator Applied and Translational Onco-Immunology Research Group
Imagen del Dr. Ignacio Melero Bermejo, especialista en Inmunología de la Clínica Universidad de Navarra.
Dr. Ignacio Melero Bermejo Curriculum
Researcher | Principal Investigator Combination Strategies for Translational Immunotherapy Research Group